Zostavax: The First Part D Vaccine
This article was originally published in RPM Report
Executive Summary
Merck's shingles vaccine Zostavax is the first vaccine for the elderly that will be launched in the Medicare Part D era. While Zostavax is covered under the drug benefit, a number of unknowns remain over who will actually pay for the vaccine.